Exclusive By Nicholas Florko Trump officials actively lobbied to deny states money for vaccine rollout last fall
Politics By Nicholas Florko Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
Exclusive By Nicholas Florko New document reveals scope and structure of Operation Warp Speed and underscores vast military involvement
Politics By Nicholas Florko Public trust in CDC, Fauci, and other top health officials is evaporating, poll finds
Special Report By Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Health By Kate Sheridan This tiny Texas company is running most of the drive-thru Covid-19 testing in the U.S.
Politics By Nicholas Florko What does the FDA’s hydroxychloroquine decision mean for Covid-19 patients or politicians? And 4 other burning questions
Prescription Politics By Lev Facher Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds
Exclusive By Nicholas Florko Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews
Health By Dalia Faheid Undocumented immigrants sought far less health care after Trump launched his campaign, new study shows
Exclusive By Rachel Cohrs The Trump administration quietly spent billions in hospital funds on Operation Warp Speed
Politics By Nicholas Florko Operation Warp Speed’s Moncef Slaoui will stay on as a consultant for Biden
STAT Summit By Andrew Joseph Chelsea Clinton wants Trump, allies to build support for a Covid-19 vaccine
Politics By Lev Facher ‘It’s going to be very, very scary’: Before Biden takes office, a precarious 10 weeks for escalating Covid-19 crisis
Politics By Nicholas Florko ‘Science was on the ballot’: How can public health recover from a rebuke at the polls?
Politics By Lev Facher, Nicholas Florko, Andrew Joseph and Kate Sheridan Doctors in Congress, new e-cigarette taxes, stem cells, and abortion rights: Here’s what STAT is watching tonight
Politics By Lev Facher Will Fauci have a job? Will the public regain trust in the FDA? 8 of the scientific institutions and traditions on the line on Tuesday
Politics By Nicholas Florko and Kate Sheridan Biden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway
Politics By Lev Facher Trump administration finalizes rule forcing insurers to disclose negotiated prices, including for drugs
The Pharmalot View By Ed Silverman ‘Where is Rudy?’: Inside Giuliani’s checkered track record as a pharma consultant
Politics By Lev Facher As Trump misleadingly boasts of ‘rounding the turn’ on Covid-19, Biden warns of ‘dark winter’
Politics By Nicholas Florko Democrats want to fire Warp Speed’s Moncef Slaoui and overhaul the program. But if Biden wins, should he?
First Opinion By Zach Nayer Community outbreaks of Covid-19 often emerge after Trump’s campaign rallies
First Opinion By Christopher M. Worsham, Lakshman Swamy and Rahul Ganatra Twitter verified our medical expertise, but we are powerless to stop Covid-19 misinformation
Special Report By Lev Facher First-of-its-kind examination shows how widely pharma showers campaign cash at the state level